DDD

3D Systems Corp. 10-K Summary: Fiscal Year Ended December 31, 1999

Business Context and Reporting Period

This Form 10-K covers the fiscal year ended December 31, 1999, for 3D Systems Corporation, a Delaware corporation headquartered in Valencia, California. The company develops, manufactures, and markets solid imaging systems, including SLA industrial systems using stereolithography technology and ThermoJet solid object printers. The company also sells consumable materials, software, and maintenance services. As of year-end, the company had sold 1,546 systems to customers in over 80 countries.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Total sales decreased 1.2% to $96.9 million. While system sales increased slightly (303 units shipped vs. 222 in 1998) driven by ThermoJet printers, service revenues declined 7.8% due to competitive pricing and the sale of the 3D Keltool business.
• Profitability Reversal: The company swung from a net profit of $2.1 million in 1998 to a net loss of $5.3 million in 1999. This was driven by lower gross margins (due to a shift toward lower-margin ThermoJet printers) and a $3.4 million increase in operating expenses.
• Expense Increases: Selling, general, and administrative (SG&A) expenses rose 15.8% to $35.3 million due to marketing for new products and management transition costs. Research and development expenses decreased 5.3% to $8.9 million.
• Non-Recurring Charges: The company incurred $3.4 million in "Other" operating expenses related to employee realignment, facility closures, and legal settlements (Centuri Litigation).
• Geographic Shift: International sales grew to 47.5% of total revenue (up from 44.1%), with European operations showing 17.8% growth.

Guidance, Outlook, and Risks

• Management Changes: In late 1999, the company engaged Regent Pacific Management Corporation to provide executive leadership, including a new CEO and CFO. An operating plan was implemented in Q4 1999 to improve margins and reduce costs, with initial impacts expected in 2000.
• Product Outlook: Management anticipates continued growth in material sales as the installed base expands. The company expects R&D expenses to remain approximately 8% of sales.
• Supplier Risk: The company relies exclusively on Ciba Specialty Chemicals (CSC) for SLA resins. CSC announced the sale of its Performance Polymer Division to Morgan Grenfell Private Equity; while the company expects contracts to be assigned, there is a risk of supply disruption or less favorable terms.
• Legal Proceedings: The company is engaged in patent infringement litigation against Aaroflex (U.S.) and Teijin Seiki (Japan). Additionally, the company settled the Centuri Litigation in July 1999 under confidential terms.
• Liquidity: The company's credit facility with Silicon Valley Bank expired in August 1999 and was not utilized. Management is establishing a new facility for working capital needs. The company believes existing cash and working capital are sufficient for the next 12 months.

Investor Verification Checklist

• Supplier Transition: Verify the status of the assignment of the Photopolymer Distribution Agreement from CSC to the new Morgan Grenfell entity.
• Cost Reduction Plan: Monitor the implementation and effectiveness of the Regent Pacific operating plan regarding SG&A reductions and margin improvements in 2000.
• Product Mix: Assess whether the shift toward lower-margin ThermoJet printers will continue to pressure overall gross margins.
• Legal Exposure: Track the progress of the Aaroflex and Teijin Seiki patent litigation and potential impacts on market share or costs.
• Debt Financing: Confirm the terms and availability of the new credit facility being established to replace the expired SVB line.